Insider Ledger

ImageneBio, Inc. (IMA) insider buying and SEC filings

ImageneBio, Inc. · CIK 1835579

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Company profile

Exchanges
Nasdaq
Industry (SIC)
Biological Products, (No Diagnostic Substances)
State of incorporation
DE
Fiscal year end
Dec 31
Former names
Ikena Oncology, Inc.

Insider activity in the last 12 months

Bought
$96K
Insiders who bought
1
Sold (not marked 10b5-1)
$17K
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Jul 16–17, 2026SaleRobert B Lally (Principal Accounting Officer) sold 3,196 shares between Jul 16 and Jul 17 at about $5.42 ($17K). Holdings down 5% to 55,582 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jul 20, 2026
Apr 14, 2026Other purchaseDavid P Bonita (Director) bought 721,292 shares indirectly; the filing does not report a price. New position of 384,689 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Apr 16, 2026
Apr 14, 2026Other purchaseORBIMED ADVISORS LLC (Director) bought 721,292 shares indirectly; the filing does not report a price. New position of 384,689 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners.SEC filing
Filed Apr 16, 2026
Dec 24, 2025Purchase (code P)Joseph P. Slattery (Director) bought 16,000 shares at $5.99 ($96K), reported as a purchase (code P). New position of 16,000 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Dec 29, 2025

12 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow IMA in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app